skip to main content
Investor Relations

Investor Relations

Press Releases

October 18, 2014
GE Healthcare’s latest innovations may help clinicians with more accurate, faster diagnosis and treatment

Read More

October 17, 2014
GE Reports 3Q’14 Operating EPS $0.38, +6% 3Q Industrial Profit +9%; Operating Margins +90 Basis Points 3Q Industrial Organic Revenues +4%; On Track for Higher End of +4-7% for 2014 Orders +22%; Record Backlog of $250B, +$21B from Year-Ago

Total-Year Framework On Track

3Q Highlights



  • 3Q operating EPS $0.38,  +6%
  • 3Q Industrial segment profit +9%, YTD +10%
  • 3Q Industrial segment organic revenues +4%, YTD +5%
  • 3Q margins +90 bps, YTD +50 bps
  • 3Q orders +22%, Growth market orders +34%, U.S. orders +25%
  • Cash generation of $7.2 billion year-to-date, $3.8 billion generated in 3Q
  • GE Capital ENI (excluding cash and equivalents) at $365 billion, down 5% vs. year-ago
Read More

October 17, 2014
GE Healthcare and Karolinska University Hospital in Sweden Partner to Improve the Treatment of Pelvic Cancer

The new care pathway for advanced pelvic cancer encourages knowledge transfer and multidisciplinary care

Read More